Skip to main content

Advertisement

Log in

Successful left hemihepatectomy and perioperative management of a patient with biliary cystadenocarcinoma, complicated with MELAS syndrome: Report of a case

  • Case Report
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like syndrome (MELAS) is a rare, fetal disease caused by a mutation in mitochondrial DNA that leads to impaired oxidative metabolism in skeletal muscle, the central nervous system, and liver function. This report presents the case of a 50-year-old woman with biliary cystadenocarcinoma complicated by MELAS who underwent a successful left hemihepatectomy. In this case, the diagnostic key for the malignant tumor was an 18F-fluorodeoxyglucose positron emission tomography study, which was useful even in a patient with MELAS, which causes abnormal glucose metabolism. The perioperative management of such patients includes special precautions to prevent lactic acidosis and deterioration of the reserved liver function after a hepatectomy, since the mitochondrial function in MELAS patients is abnormal. The patient in this report has remained free of liver dysfunctions and cancer recurrence for 2 years following the hepatectomy. This is the first report of a successful major hepatectomy for a patient with MELAS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sprolue DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 2008;1142:133–158.

    Article  Google Scholar 

  2. Thambisetty M, Newman NJ. Diagnosis and management of MELAS. Expert Rev Mol Diagn 2004;4:631–644.

    Article  CAS  PubMed  Google Scholar 

  3. Scaglia, Northrop JL. The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options. CNS Drugs 2006;20:443–464.

    Article  CAS  PubMed  Google Scholar 

  4. Mita S, Tokunaga M, Kumamoto T, Uchino M, Nonaka I, Ando M. Mitochondrial DNA mutation and muscle pathology in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Muscle Nerve 1995;3:S113–S118.

    Article  CAS  PubMed  Google Scholar 

  5. Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Kärppä M. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes: prevalence of the mutation in an adult population. Am J Hum Genet. 1998;63:447–454.

    Article  CAS  PubMed  Google Scholar 

  6. Manwaring N, Jones MM, Wang JJ, Rochtchina E, Howard C, Mitchell P, et al. Population prevalence of the MELAS A3243G mutation. Mitochondrion 2007;7:230–233.

    Article  CAS  PubMed  Google Scholar 

  7. Sarnat HB, Marín-García J. Pathology of mitochondrial encephalopathies. Can J Neurol Sci 2005;32:152–166.

    PubMed  Google Scholar 

  8. Marko P, Gabrielli A, Caruso LJ. Case conference of the University of Florida “Too much lactate or too little liver?” J Clin Anesth 2004;16:389–395.

    Article  PubMed  Google Scholar 

  9. Vilela H, Garcìa-Fernández J, Parodi E, Reinoso-Barbero F, Durán P, Gilsanz F. Anesthetic management of a patient with MERRF syndrome. Paediatr Anesth 2005;15:77–79.

    Article  Google Scholar 

  10. Sasano N, Fujita Y, So M, Sobue K, Sasano H, Katsuya H. Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy. J Anesth 2007;21:72–75.

    Article  PubMed  Google Scholar 

  11. Chioléro R, Tappy L, Gillet M, Revelly JP, Roth H, Cayeux C, et al. Effect of major hepatectomy on glucose and lactate metabolism. Ann Surg 1999;229:505–513.

    Article  PubMed  Google Scholar 

  12. Furukawa H, Ikuma H, Asakura-Yokoe K, Uesaka K. Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology. Eur Radiol 2008;18:2841–2847.

    Article  PubMed  Google Scholar 

  13. Higashi T, Tamaki N, Honda T, Torizuka T, Kimura T, Inokuma T, et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. J Nucl Med 1997;38:1337–1344.

    CAS  PubMed  Google Scholar 

  14. Higashi T, Tamaki N, Torizuka T, Nakamoto Y, Sakahara H, Kimura T, et al. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. J Nucl Med 1998;39:1727–1735.

    CAS  PubMed  Google Scholar 

  15. Läuffer JM, Baer HU, Maurer CA, Stoupis C, Zimmerman A, Büchler MW, et al. Biliary cystadenocarcinoma of the liver: the need for complete resection. Eur J Cancer 1998;34:1845–51.

    Article  PubMed  Google Scholar 

  16. Pojchamarnwiputh S, Na Chiangmai W, Chotirosniramit A, Lertprasertsuke N. Computed tomography of biliary cystadenoma and biliary cystadenocarcinoma. Singapore Med J 2008;49:392–396.

    CAS  PubMed  Google Scholar 

  17. Del Poggio P, Buonocore M. Cystic tumors of the liver: a practical approach. World J Gastroenterol 2008;14:3616–3620.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohno, A., Mori, A., Doi, R. et al. Successful left hemihepatectomy and perioperative management of a patient with biliary cystadenocarcinoma, complicated with MELAS syndrome: Report of a case. Surg Today 40, 878–882 (2010). https://doi.org/10.1007/s00595-009-4145-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-009-4145-z

Key words

Navigation